Adaptive Pharmacogenomics, LLC

Clinical development for personalized medicine

Saturday, May 19, 2012 | 7:14 PM

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.

J Clin Pharm Ther. 2010 Jun;35(3):343-50

Authors: Lee VW, Chau TS, Chan AK, Lee KK, Waye MM, Ling TK, Chan FK

Our study aimed to assess the effectiveness of esomeprazole or rabeprazole in combination with amoxicillin and clarithromycin for the eradication of Helicobacter pylori in Hong Kong non-ulcer dyspepsia (NUD) patients.

PMID: 20831535 [PubMed - indexed for MEDLINE]

Dec 19, 2010 03:23 AMwww.ncbi.nlm.nih.gov
© 2008 — 2012 Adaptive Pharmacogenomics, LLC